Overview
Roy Brod is an Ophthalmologist in Lancaster, Pennsylvania. Dr. Brod is rated as an Experienced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Hepatic Hemangioma. Dr. Brod is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2150 Harrisburg Pike, Suite 370, Lancaster, PA 17601
Additional Areas of Focus
Dr. Brod has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Johns Hopkins Hospital
Akrit Sodhi, M.D, Ph.D., is an Associate Professor of Ophthalmology at the Wilmer Eye Institute and holds the Branna and Irving Sisenwein Professorship in Ophthalmology. Dr. Sodhi specializes in the medical and surgical management of complex vitreoretinal diseases. Dr. Sodhi was trained at the University of California at Los Angeles (UCLA), the University of California at Davis, and the National Institutes of Health. After obtaining his M.D. and Ph.D., he interned at Sinai Hospital in Baltimore and completed his Ophthalmology Residency training at the Wilmer Eye Institute at Johns Hopkins in 2008. He then pursued a fellowship in vitreoretinal surgery at Wilmer where he also served as the Assistant Chief of Service (Chief Resident). Dr. Sodhi joined the faculty of the Retina Division at Wilmer in 2010. His research interests, currently sponsored by grants from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) and HIF-regulated genes in ocular diseases, including diabetic eye disease, age-related macular degeneration, sickle cell retinopathy, retinal vein occlusions, and uveal melanoma. Dr. Sodhi's lab has identified novel therapeutic targets for the treatment of these vision-threatening diseases. Dr. Sodhi is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Late-Onset Retinal Degeneration.
Office Of Spage Yee, MD
Spage Yee is an Ophthalmologist in Lancaster, Pennsylvania. Dr. Yee is rated as an Advanced provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Pinguecula, Cataract, Hyphema, and Metastatic Uveal Melanoma. Dr. Yee is currently accepting new patients.
Barry Malloy is an Ophthalmologist in Wyomissing, Pennsylvania. Dr. Malloy is rated as a Distinguished provider by MediFind in the treatment of Metastatic Uveal Melanoma. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Punctate Inner Choroidopathy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Brod isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationDr. Brod isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Advanced
- Choroid Plexus CarcinomaDr. Brod isAdvanced. Learn about Choroid Plexus Carcinoma.
- Diabetic RetinopathyDr. Brod isAdvanced. Learn about Diabetic Retinopathy.
- EndophthalmitisDr. Brod isAdvanced. Learn about Endophthalmitis.
- Hepatic HemangiomaDr. Brod isAdvanced. Learn about Hepatic Hemangioma.
- NeuroretinitisDr. Brod isAdvanced. Learn about Neuroretinitis.
- Retinal DetachmentDr. Brod isAdvanced. Learn about Retinal Detachment.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Bietti Crystalline Dystrophy (BCD)Dr. Brod isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- CataractDr. Brod isExperienced. Learn about Cataract.
- Central Serous ChorioretinopathyDr. Brod isExperienced. Learn about Central Serous Chorioretinopathy.
- Cone DystrophyDr. Brod isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta

